Acquired long QT syndrome and phosphoinositide 3-kinase.

about

Cardiac Arrhythmias and Antiarrhythmic Drugs: An Autophagic Perspective.An in Vitro Assay of hERG K + Channel Potency for a New EGFR Inhibitor FHND004.

P2860

Q52727269-1B2D00DE-A548-4DEB-9130-BED437EF1CCD Q55175160-7A2FBC9A-7B7D-4D25-BDB4-1DA543278BA6

P2860

Acquired long QT syndrome and phosphoinositide 3-kinase.

Item

http://www.wikidata.org/entity/Q39421620

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Acquired long QT syndrome and phosphoinositide 3-kinase.

@en

Acquired long QT syndrome and phosphoinositide 3-kinase.

@nl

type

Item

label

Acquired long QT syndrome and phosphoinositide 3-kinase.

@en

Acquired long QT syndrome and phosphoinositide 3-kinase.

@nl

prefLabel

Acquired long QT syndrome and phosphoinositide 3-kinase.

@en

Acquired long QT syndrome and phosphoinositide 3-kinase.

@nl

P1476

Acquired long QT syndrome and phosphoinositide 3-kinase.

@en

P2093

Ira S Cohen

http://www.w3.org/2001/XMLSchema#string

Lisa M Ballou

http://www.w3.org/2001/XMLSchema#string

Richard Z Lin

http://www.w3.org/2001/XMLSchema#string

P2860

Drug induced QT prolongation and torsades de pointes

Simulation of the undiseased human cardiac ventricular action potential: model formulation and experimental validation

The nuts and bolts of AGC protein kinases

The emerging mechanisms of isoform-specific PI3K signalling

High-throughput screening of tyrosine kinase inhibitor cardiotoxicity with human induced pluripotent stem cells.

Screening for acute IKr block is insufficient to detect torsades de pointes liability: role of late sodium current.

Drug-induced long QT syndrome

Protein trafficking abnormalities: a new mechanism in drug-induced long QT syndrome.

Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development.

PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting.

P304

451-459

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.TCM.2017.05.005

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28687226

http://www.w3.org/2001/XMLSchema#string

P932

5582013

http://www.w3.org/2001/XMLSchema#string

Acquired long QT syndrome and phosphoinositide 3-kinase.

about

P2860

P2860

Acquired long QT syndrome and phosphoinositide 3-kinase.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932